Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/277
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms
Description: Subject matter which contains a six-membered heterocyclic ring consisting of one nitrogen and five carbon atoms.

Sub-classes under this class:

Class Number	Class Name	Patents
514/336	Additional hetero ring containing	850
514/354	C=o bonded directly to the six-membered hetero ring	436
514/345	Chalcogen bonded directly to ring carbon of the six-membered hetero ring	722
514/344	Cyano bonded directly to the six-membered hetero ring	250
514/352	Nitrogen attached directly to the six-membered hetero ring by nonionic bonding	779
514/357	Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding	1,297
514/315	Piperidines	784
514/332	Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms	547
514/279	Polycyclo ring system having the six-membered hetero ring as one of the cyclos	278
514/278	Spiro ring system	798
514/358	The ring nitrogen of the six-membered hetero ring is pentavalent (e.g., quaternary pyridinium salt, etc.)	152

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Patent Number	Title Of Patent	Date Issued
5834467	HIV protease inhibitors	Nov. 10, 1998
5833742	Phenylamides as marine antifouling agents	Nov. 10, 1998
5827852	Coated pharmaceutical compositions	Oct. 27, 1998
5824685	Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists	Oct. 20, 1998
5821231	CS-1 peptidomimetics, compositions and methods of using same	Oct. 13, 1998
5807586	Method of dietary supplementation	Sep. 15, 1998
5798373	Tri-substituted phenyl derivatives useful as PDE IV inhibitors	Aug. 25, 1998
5789449	Treatment of symptoms associated with premenstrual disorders	Aug. 4, 1998
5786354	Tri-substituted phenyl derivatives and processes for their preparation	Jul. 28, 1998
5780486	Heterocyclic compounds	Jul. 14, 1998
5780478	Tetra-substituted phenyl derivatives	Jul. 14, 1998
5780477	Trisubstituted phenyl derivatives and processes for their preparation	Jul. 14, 1998
5767151	3,3-(disubstituted) cyclohexan-1-ylidine acetate dimers and related compounds	Jun. 16, 1998
5767154	5-trans-prostaglandins of the F series and their use as ocular hypotensives	Jun. 16, 1998
5763461	Therapeutic phenoxyalkylheterocycles	Jun. 9, 1998
5747542	Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity	May. 5, 1998
5744501	Method for treating late luteal phase dysphoric disorder	Apr. 28, 1998
5741796	Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption	Apr. 21, 1998
5739144	Trisubstituted phenyl derivatives	Apr. 14, 1998
5731313	Use of anthracyclinone derivatives in amyloidosis	Mar. 24, 1998
5731314	Pharamceutical compositions for prevention and treatment of tourette's syndrome	Mar. 24, 1998
5723499	Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof	Mar. 3, 1998
5721243	Radiopharmaceutical agents for the detection of Alzheimers disease	Feb. 24, 1998
5719182	Endothelin receptor anatagonists	Feb. 17, 1998
5719150	1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same	Feb. 17, 1998
5719183	Endothelin receptor antagonists	Feb. 17, 1998
5716985	Endothelin receptor antagonists	Feb. 10, 1998
5716961	Treatment of tinnitus using neuroprotective agents	Feb. 10, 1998
5714491	Peptidyl derivatives as metalloproteinase inhibitors	Feb. 3, 1998
5710160	Diphenyl pyridyl ethane derivatives as PDE IV inhibitors	Jan. 20, 1998
5698565	Use of phenoxy-pyridine derivatives	Dec. 16, 1997
5688805	Tricyclic derivatives, compositions and methods of use	Nov. 18, 1997
5686460	Carbocyclic diarylmethylene derivatives, processes for their preparation and their uses in therapeutics	Nov. 11, 1997
5686484	Milbemycin derivatives, their preparation and their use	Nov. 11, 1997
5679696	Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group	Oct. 21, 1997
5672597	Acetamide derivative	Sep. 30, 1997
5672609	Pyridine compounds, intermediates compositions and methods of use	Sep. 30, 1997
5668136	Trisubstituted benzene derivatives, composition and methods of treatment	Sep. 16, 1997
5658942	Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition	Aug. 19, 1997
5656636	Pyridine compounds for treating leukotriene-related diseases	Aug. 12, 1997
5656656	Tartronic acids, their acetalic ethers and O-esters	Aug. 12, 1997
5656635	5-trans-alcohols and their use as ocular hypotensives	Aug. 12, 1997
5652252	Benzocycloheptenes	Jul. 29, 1997
5646158	1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds	Jul. 8, 1997
5643914	Pharmaceutical pyridine compounds	Jul. 1, 1997
5639765	Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting bone loss	Jun. 17, 1997
5639746	Hydroxamic acid-containing inhibitors of matrix metalloproteases	Jun. 17, 1997
5633258	Pyridine compounds for treating leukotriene-related diseases	May. 27, 1997
5633257	Cyclo(alkyl and alkenyl)phenyl-alkenylyl(aryl and heteroaryl)compounds and pharmaceutical compositions containing them	May. 27, 1997
5631262	Pyridine compounds for treating leukotriene-related diseases	May. 20, 1997